TOP > News Release > Products
News Release

New Release Browse by Category

Products News Release

RSS
Browse by Year
2010
2009
2008
2007
2006
2005
Browse by Category
Corporate
R&D
Products
Others

2010

2010.02.15
FDA Approves Benicar(R) for the Treatment of High Blood Pressure in Children and Adolescents aged 6-16(1)

2009

2009.11.16
Challenge to UK Levofloxacin SPC and Underlying Patent is Over
2009.08.06
Effient(TM) is Now Available in Pharmacies
2009.08.03
THE U.S. DISTRICT COURT HAS ISSUED A DECISION IN OUR FAVOR IN OUR U.S. PATENT LITIGATION REGARDING BENICAR(R), BENICAR HCT(R) AND AZOR(R)
2009.04.08
FIRST LAUNCH OF EFIENT® WORLDWIDE TAKES PLACE IN THE UK

2008

2008.11.13
DAIICHI SANKYO EUROPE GmbH announce SEVIKAR® a new fixed dose combination treatment for essential hypertension
2008.06.18
New Study Shows Benicar(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering
2008.06.05
DAIICHI SANKYO COMMENCES PATENT LITIGATION AGAINST MYLAN
AND MATRIX IN THE UNITED STATES
2008.05.13
FOREST LABORATORIES, INC. AND DAIICHI SANKYO, INC. ANNOUNCE
THE TERMINATION OF THE AZOR CO-PROMOTION AGREEMENT
2008.04.16
Welchol(R) Added to the American College of Endocrinology/American Association of Clinical Endocrinologists "Road Maps to Achieve Glycemic Control in Patients with Type 2 Diabetes Mellitus"
2008.02.01
Analytical Results for Women from Large Scale Clinical Trial MEGA Study Employing the Hypercholesterolemia Drug Mevalotin(R) Published

2007

2007.09.28
AZOR(TM) Receives FDA Approval for Treatment of High Blood Pressure
2007.07.12
Amgen Grants Daiichi Sankyo Exclusive Rights to Develop and
Commercialize Denosumab in Japan
2007.06.26
DAIICHI SANKYO COMMENCES PATENT LITIGATION AGAINST MYLAN IN THE UNITED STATES
2007.06.14
Canadian Levofloxacin Patent Upheld by Federal Appeal Court
2007.05.22
Amlodipine and Olmesartan Study Results Released;
Late Breaker Presented at American Society of Hypertension
Twenty-Second Annual Scientific Meeting (ASH 2007)
First Release of Data for New Combination
2007.05.14
Announce on NDA Submission for Injectafer(R)
2007.01.05
DAIICHI SANKYO, INC. ANNOUNCES FILING OF SUPPLEMENTAL NEW DRUG APPLICATION FOR WELCHOL IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS

2006

2006.11.29
DAIICHI SANKYO, INC. ANNOUNCES FILING OF NEW DRUG APPLICATION FOR AMLODIPINE BESYLATE / OLMESARTAN MEDOXOMIL COMBINATION FOR THE TREATMENT OF HYPERTENSION
2006.08.02
SANKYO COMMENCES PATENT LITIGATION AGAINST BENICAR® ANDA FILING IN THE UNITED STATES
2006.07.14
Sales Agreement for EVISTA® Reached in Europe
Browse by Year
2010
2009
2008
2007
2006
2005
Browse by Category
Corporate
R&D
Products
Others